255 related articles for article (PubMed ID: 32818122)
1. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
Asemota J; Saleh M; Igbinovia O; Burns D
Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
Pahari H; Raj A; Sawant A; Ahire DS; Rathod R; Rathi C; Sankalecha T; Palnitkar S; Raut V
World J Transplant; 2024 Mar; 14(1):88833. PubMed ID: 38576752
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Current status of therapy for hepatocellular carcinoma.
Corey KE; Pratt DS
Therap Adv Gastroenterol; 2009 Jan; 2(1):45-57. PubMed ID: 21180533
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
[TBL] [Abstract][Full Text] [Related]
6. Role of liver transplantation for hepatocellular carcinoma.
Kumaran V
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S97-S103. PubMed ID: 25755618
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: a review.
Balogh J; Victor D; Asham EH; Burroughs SG; Boktour M; Saharia A; Li X; Ghobrial RM; Monsour HP
J Hepatocell Carcinoma; 2016; 3():41-53. PubMed ID: 27785449
[TBL] [Abstract][Full Text] [Related]
8. Liver Transplantation Update: 2014.
Dogan S; Gurakar A
Euroasian J Hepatogastroenterol; 2015; 5(2):98-106. PubMed ID: 29201702
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation for hepatocellular carcinoma.
Lee SG; Moon DB
Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Nadarevic T; Colli A; Giljaca V; Fraquelli M; Casazza G; Manzotti C; Štimac D; Miletic D
Cochrane Database Syst Rev; 2022 May; 5(5):CD014798. PubMed ID: 35521901
[TBL] [Abstract][Full Text] [Related]
11. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
12. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).
Ishizaki Y; Kawasaki S
J Gastroenterol; 2008; 43(1):18-26. PubMed ID: 18297431
[TBL] [Abstract][Full Text] [Related]
13. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
Degroote H; Piñero F; Costentin C; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas AL; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Di Benedetto F; Duque SH; Salame E; Cillo U; Gadano A; Vanlemmens C; Fagiuoli S; Rubinstein F; Burra P; Cherqui D; Silva M; Van Vlierberghe H; Duvoux C;
JHEP Rep; 2021 Oct; 3(5):100331. PubMed ID: 34485882
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices.
Rich NE; Parikh ND; Singal AG
Curr Treat Options Gastroenterol; 2017 Jun; 15(2):296-304. PubMed ID: 28425018
[TBL] [Abstract][Full Text] [Related]
15. Current management of hepatocellular carcinoma.
Crissien AM; Frenette C
Gastroenterol Hepatol (N Y); 2014 Mar; 10(3):153-61. PubMed ID: 24829542
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
17. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
18. Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.
Gunay Y; Guler N; Yaprak O; Dayangac M; Akyildiz M; Altaca G; Yuzer Y; Tokat Y
Indian J Surg; 2015 Dec; 77(Suppl 3):950-6. PubMed ID: 27011489
[TBL] [Abstract][Full Text] [Related]
19. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
